Gene therapy for a form of blindness, called Leber’s congenital amaurosis, is now being tested on human volunteers after proving successful in earlier animal trials. Researchers hope this will eventually lead to a breakthrough in other forms of sight conditions and even pave the way for gene therapy in more complex organs. LOUISE FRAMPTON reports.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
